GSK’s Jemperli Combo Shows Improved PFS in Phase III Ovarian Cancer Trial
UK-based GSK plc (NYSE: GSK) has announced a positive readout from the Phase III FIRST-ENGOT-OV44...
Pfizer’s Braftovi Receives FDA Approval for Metastatic Colorectal Cancer Treatment
US-based Pfizer (NYSE: PFE) has announced receiving an indication extension approval from the US Food...
Eli Lilly’s Zepbound Receives FDA Approval for Moderate-to-Severe OSA and Obesity
US pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has revealed that the US Food...
Novo Nordisk’s Alhemo Receives FDA Approval for Hemophilia A and B Prophylaxis
Denmark-based Novo Nordisk A/S (NYSE: NVO) has announced that the US Food and Drug Administration...
Boehringer Ingelheim-SEC Joint Incubator Launches in Shenzhen’s Luohu District
On December 23, the Boehringer Ingelheim-SEC Joint innovative incubator was inaugurated in Luohu District, Shenzhen....
CStone Pharmaceuticals Initiates First-in-Human Trial for PD-1/VEGF/CTLA-4 Trispecific Antibody CS2009
China-based CStone Pharmaceuticals (HKG: 2616) has announced the clinical filing for its CS2009, a PD-1/VEGF/CTLA-4...
Becton, Dickinson and Co. Launches RMB1.332 Billion Factory in Jiangsu for Pre-Filled Syringes
US-based Becton, Dickinson and Co., (BD) has officially put into operation its new factory in...
C.Q. Pharmaceutical Holding to Come Under SASAC’s Indirect Control via Genertec Acquisition
C.Q. Pharmaceutical Holding Co., Ltd (SHE: 000950), a Chongqing-based pharmaceutical company, is set to be...
Yifan Pharmaceutical’s Evive Biotech Receives ANVISA Approval for Ryzneuta
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) has announced that its subsidiary, Evive Biotech Ltd,...
Changchun BCHT Biotechnology Receives NMPA Approval for HSV-2 mRNA Vaccine LVRNA101
Changchun BCHT Biotechnology Co., Ltd (SHA: 688276), a China-based biotechnology company, has announced receiving clinical...
Shenzhen Chipscreen Biosciences Gets NMPA Approval for CS231295 Solid Tumor Study
Shenzhen Chipscreen Biosciences Co., Ltd (SHA: 688321), a China-based biopharmaceutical company, has announced receiving the...
Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval to Test SHR-1681 in Clinical Trials
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has announced that it has received approval from...
CSPC Pharmaceutical’s SYH9017 Receives NMPA Clearance for Weight Management Clinical Trial
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced clinical clearance from the National...
CSPC Pharmaceutical Group Receives NMPA Approval for Two Antibody-Drug Conjugates
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced that it has received separate...
CanSino Biologics Initiates Phase I/II Study for CS-2036 Polio Vaccine with Gates Foundation Support
CanSino Biologics (SHA: 688185, HKG: 6185) has announced the initiation of a Phase I/II study...
Innovent Biologics’ Taletrectinib Wins NMPA Approval for ROS1+ NSCLC Treatment
China-based Innovent Biologics, Inc. (HKG: 1801) has announced receiving marketing approval from the National Medical...
MicroPort Scientific Corp. Receives NMPA Approval for FireRaptor Coronary Atherectomy System
Shanghai-based medical device giant MicroPort Scientific Corp. (HKG: 0853) has announced receiving marketing approval from...
Biopharma Company TransThera Sciences (Nanjing) Gets Green Light for HK IPO
On December 20, 2024, the China Securities Regulatory Commission confirmed the listing filing for TransThera...
YolTech Therapeutics’ YOLT-201 Advances in ATTR Treatment Clinical Trial
Shanghai, China, December 21, 2024 — YolTech Therapeutics today announced that its proprietary in vivo...
Wuhan Weike Medical Technology Secures Series C Funding to Boost Cardiovascular Innovation
Wuhan Weike Medical Technology Co., Ltd., known as “Weike Medical,” has officially announced the successful...